Molecular basis of receptor/G-protein-coupling selectivity

Pharmacology and Therapeutics

Volumn 80, Issue 3, 1998, Pages 231-264

  Wess, Jürgen ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

G protein activation; G protein coupled receptors; G proteins; Receptor activation; Receptor G protein coupling selectivity; Receptor G protein interactions

Indexed keywords

COMPLEMENTARY RNA; GUANINE NUCLEOTIDE BINDING PROTEIN; LIGAND; RECEPTOR PROTEIN;

ALPHA CHAIN; AMINO TERMINAL SEQUENCE; BIOCHEMISTRY; BIOPHYSICS; CARBOXY TERMINAL SEQUENCE; GENE ACTIVATION; GENE SEQUENCE; GENETIC LINKAGE; GENETIC MODEL; IMMUNOASSAY; IMMUNOPRECIPITATION; MOLECULAR CLONING; NUCLEIC ACID PROBE; PALMITOYLATION; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN STRUCTURE; REVIEW; RNA TRANSLATION;

AMINO ACID SEQUENCE; ANIMALS; CLONING, MOLECULAR; GTP-BINDING PROTEINS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; RECEPTORS, CELL SURFACE;

EID: 0032402450     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(98)00030-8     Document Type: Review

References (281)

1. 135 sequence in rhodopsin. J. Biol. Chem. 271:1996;25406-25411.
2. Acharya S., Saad Y., Karnik S.S. Transducin-α C-terminal peptide binding site consists of C-D and E-F loops of rhodopsin. J. Biol. Chem. 272:1997;6519-6524.
3. Albert P.A., Morris S.J. Antisense knockouts. molecular scalpels for the dissection of signal transduction Trends Pharmacol. Sci. 15:1994;250-254.
4. Alblas J., van Etten I., Khanum A., Moolenaar W.H. C-terminal truncation of the neurokinin-2 receptor causes enhanced and sustained agonist-induced signalling. role of receptor phosphorylation in signal attenuation J. Biol. Chem. 270:1995;8944-8951.
5. Altenbach C., Yang K., Farrens D.L., Farahbakhsh Z.T., Khorana H.G., Hubbell W.L. Structural features and light-dependent changes in the cytoplasmic interhelical E-F loop region of rhodopsin. a site-directed spin labeling study Biochemistry. 35:1996;12470-12478.
6. Amatruda T.T. III, Gerard N.P., Gerard C., Simon M.I. Specific interactions of chemoattractant factor receptors with G-proteins. J. Biol. Chem. 268:1993;10139-10144.
7. Amatruda T.T. III, Dragas-Graonic S., Holmes R., Perez H.D. Signal transduction by the formyl peptide receptor. studies using chimeric receptors and site-directed mutagenesis define a novel domain for interactions with G-proteins J. Biol. Chem. 270:1995;28010-28013.
8. 2 receptor transduce both intracellular calcium and cAMP signals. Biochemistry. 33:1994;14496-14502.
9. Ancellin N., Preisser L., Corman B., Morel A. Role of protein kinase C and carboxyl-terminal region in acute desensitization of vasopressin V1a receptor. FEBS Lett. 413:1997;323-326.
10. Aquilla E., Whelchel A., Knot H.J., Nelson M., Posada J. Activation of multiple mitogen-activated protein kinase signal transduction pathways by the endothelin B receptor requires the cytoplasmic tail. J. Biol. Chem. 271:1996;31572-31579.
11. Arai H., Charo I.F. Differential regulation of G-protein-mediated signaling by chemokine receptors. J. Biol. Chem. 271:1996;21814-21819.
12. Arnis S., Fahmy K., Hofmann K.P., Sakmar T.P. A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. J. Biol. Chem. 269:1994;23879-23881.
13. Arora K.K., Sakai A., Catt K. Effects of second intracellular loop mutations on signal transduction and internalization of the gonadotropin-releasing hormone receptor. J. Biol. Chem. 270:1995;22820-22826.
14. Arora K.K., Cheng Z., Catt K. Mutations in the conserved DRS motif in the second intracellular loop of the gonadotropin-releasing hormone receptor affect expression, activation, and internalization. Mol. Endocrinol. 11:1997;1203-1212.
15. Baldwin J.M. The probable arrangement of the helices in G protein-coupled receptors. EMBO J. 12:1993;1693-1703.
16. Baldwin J.M. Structure and function of receptors coupled to G proteins. Curr. Opin. Cell Biol. 6:1994;180-190.
17. Baldwin J.M., Schertler G.F.X., Unger V.M. An alpha-carbon template for the transmembrane helices in the rhodopsin family of G-protein-coupled receptors. J. Mol. Biol. 272:1997;144-164.
18. Barr A.J., Brass L.F., Manning D.R. Reconstitution of receptors and GTP-binding regulatory proteins (G proteins) in Sf9 cells. a direct evaluation of selectivity in receptor-G protein coupling J. Biol. Chem. 272:1997;2223-2229.
19. Berger E.A. HIV entry and tropism. the chemokine receptor connection AIDS. 11(Suppl. A):1997;S3-S16.
20. q/11 by the m3 muscarinic acetylcholine receptor. J. Biol. Chem. 270:1995;17741-17748.
21. Blüml K., Mutschler E., Wess J. Identification of an intracellular tyrosine residue critical for muscarinic receptor-mediated stimulation of phosphatidyl inositol hydrolysis. J. Biol. Chem. 269:1994;402-405. a.
22. Blüml K., Mutschler E., Wess J. Functional role of a cytoplasmic aromatic amino acid in muscarinic receptor-mediated activation of phospholipase C. J. Biol. Chem. 269:1994;11537-11541. b.
23. Blüml K., Mutschler E., Wess J. Insertion mutagenesis as a tool to predict the secondary structure of a muscarinic receptor domain determining specificity of G-protein coupling. Proc. Natl. Acad. Sci. USA. 91:1994;7980-7984. c.
24. Bonner T.I., Buckley N.J., Young A.C., Brann M.R. Identification of a family of muscarinic acetylcholine receptor genes. Science. 237:1987;527-532.
25. s by cholera toxin is potentiated by agonist activation of β-adrenergic receptors in the absence of GTP. J. Biol. Chem. 268:1993;17026-17029.
26. Bourne H.R. How receptors talk to trimeric G proteins. Curr. Opin. Cell Biol. 9:1997;134-142.
27. Bouvier M., Chidiac P., Hebert T.E., Loisel T.P., Moffett S., Mouillac B. Dynamic palmitoylation of G-protein-coupled receptors in eucaryotic cells. Methods Enzymol. 250:1995;300-314.
28. 2+-sensing receptor from bovine parathyroid. Nature. 366:1993;575-580.
29. Brown E.M., Segre G.V., Goldring S.R. Serpentine receptors for parathyroid hormone, calcitonin and extracellular calcium ions. Baillieres Clin. Endocrinol. Metab. 10:1996;123-161.
30. Buck L., Axel R. A novel multigene family may encode odorant receptors. a molecular basis for odor recognition Cell. 65:1991;175-187.
31. sα and is not a consequence of phosphoinositidase C activation. Biochem. J. 315:1996;883-888.
32. Burns C.M., Chu H., Rueter S.M., Hutchinson L.K., Canton H., Sanders-Bush E., Emeson R.B. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature. 387:1997;303-308.
33. Burstein E.S., Spalding T.A., Hill-Eubanks D., Brann M.R. Structure-function of muscarinic receptor coupling to G proteins. random saturation mutagenesis identifies a critical determinant of receptor affinity for G proteins J. Biol. Chem. 270:1995;3141-3146.
34. 1A receptor in Sf9 cells. reconstitution of a coupled phenotype by co-expression of mammalian G protein subunits J. Biol. Chem. 270:1995;18691-18699.
35. Carlson S.A., Chatterjee T.K., Fisher R.A. The third intracellular domain of the platelet-activating factor receptor is a critical determinant in receptor coupling to phosphoinositide phospholipase C-activating G proteins. J. Biol. Chem. 271:1996;23146-23153.
36. 2A-adrenergic receptor to multiple G-proteins. a simple approach for estimating receptor-G protein coupling efficiency in a transient expression system J. Biol. Chem. 269:1994;5730-5734.
37. s. Mol. Pharmacol. 41:1992;1061-1065.
38. Clapham D.E., Neer E.J. G protein βγ subunits. Annu. Rev. Pharmacol. Toxicol. 37:1997;167-203.
39. Cohen G.B., Yang T., Robinson P.R., Oprian D.D. Constitutive activation of opsin. influence of charge at position 134 and size at position 296 Biochemistry. 32:1993;6111-6115.
40. Conklin B.R., Bourne H.R. Structural elements of Gα subunits that interact with Gγ receptors, and effectors. Cell. 73:1993;631-641.
41. iα Nature. 363:1993;274-276.
42. sα that alter the fidelity of receptor activation. Mol. Pharmacol. 50:1996;885-890.
43. Conn P.J., Pin J.-P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol. 37:1997;205-237.
44. 1-adrenergic receptor involved in coupling to phosphatidylinositol hydrolysis and enhanced sensitivity of biological function. Proc. Natl. Acad. Sci. USA. 87:1990;2896-2900.
45. 1-adrenergic receptor determine the selectivity of coupling to phosphatidylinositol hydrolysis. J. Biol. Chem. 267:1992;1633-1639.
46. Coughlin S.R. Expanding horizons for receptors coupled to G proteins. diversity and disease Curr. Opin. Cell. Biol. 6:1994;191-197.
47. 2-adrenergic receptor to different G proteins by protein kinase A. Nature. 390:1997;88-91.
48. i2α with interleukin-8 receptors. J. Biol. Chem. 271:1996;12783-12789.
49. D'Angelo D.D., Eubank J.J., Davis M.G., Dorn G.W. II Mutagenic analysis of platelet thromboxane receptor cysteines. roles in ligand binding and receptor-effector coupling J. Biol. Chem. 271:1996;6233-6240.
50. o proteins in rat neuroendocrine cell lines. J. Physiol. 502:1997;321-333.
51. s protein α subunit after activation by the β-adrenergic receptor or cholera toxin. J. Biol. Chem. 268:1993;23769-23772.
52. Dippel E., Kalkbrenner F., Wittig B., Schultz G. A heterotrimeric G protein complex couples the m1 muscarinic receptor to phospholipase C-β Proc. Natl. Acad. Sci. USA. 93:1996;1391-1396.
53. Dohlman H.G., Thorner J., Caron M.G., Lefkowitz R.J. Model systems for the study of seven-transmembrane-segment receptors. Annu. Rev. Biochem. 60:1991;653-688.
54. Dratz E.A., Furstenau J.E., Lambert C.G., Thireault D.L., Rarick H., Schepers T., Pakhlevaniants S., Hamm H.E. NMR structure of a receptor-bound G-protein peptide. Nature. 363:1993;276-281.
55. Dulac C., Axel R. A novel family of genes encoding putative pheromone receptors in mammals. Cell. 83:1995;195-206.
56. i coupling domains J. Biol. Chem. 271:1996;12826-12832.
57. s J. Biol. Chem. 267:1992;15795-15801.
58. Elling C.E., Thirstrup K., Nielsen S.M., Hjorth S.A., Schwartz T.W. Metal-ion sites as structural and functional probes of helix-helix interactions in 7TM receptors. Ann. NY Acad. Sci. 814:1997;142-151.
59. Ernst O.P., Hofmann K.P., Sakmar T.P. Characterization of rhodopsin mutants that bind transducin but fail to induce GTP nucleotide uptake. classification of mutant pigments by fluorescence, nucleotide release, and flash-induced light-scattering assays J. Biol. Chem. 270:1995;10850-10856.
60. Evans P.D., Robb S., Cheek T.R., Reale V., Hannan F.L., Swales L.S., Hall L.M., Midgley J.M. Agonist-specific coupling of G protein-coupled receptors to second-messenger systems. Prog. Brain Res. 106:1995;259-268.
61. Exton J.H. Regulation of phosphoinositide phospholipases by hormones, neurotransmitters, and other agonists linked to G proteins. Annu. Rev. Pharmacol. Toxicol. 36:1996;481-509.
62. Farahbakhsh Z.T., Hideg K., Hubbell W.L. Photoactivated conformational changes in rhodopsin. a time-resolved spin label study Science. 262:1993;1416-1419.
63. Farahbakhsh Z.T., Ridge K.D., Khorana H.G., Hubbell W.L. Mapping light-dependent structural changes in the cytoplasmic loop connecting helices C and D in rhodopsin. a site-directed spin labeling study Biochemistry. 34:1995;8812-8819.
64. Farrens D.L., Altenbach C., Yang K., Hubbell W.L., Khorana H.G. Requirement of rigid-body motion of transmembrane helices for light activation of rhodopsin. Science. 274:1996;768-770.
65. 1 adenosine receptors in Sf9 cell membranes with recombinant G proteins of defined composition. Mol. Pharmacol. 50:1996;1587-1595.
66. 1 adenosine receptors and G proteins in phospholipid vesicles. βγ-subunit composition influences guanine nucleotide exchange and agonist binding Biochemistry. 36:1997;16288-16299.
67. Franke R.R., König B., Sakmar T.P., Khorana H.G., Hofmann K.P. Rhodopsin mutants that bind but fail to activate transducin. Science. 250:1990;123-125.
68. Franke R.R., Sakmar T.P., Graham R.M., Khorana H.G. Structure and function in rhodopsin. studies of the interaction between the rhodopsin cytoplasmic domain and transducin J. Biol. Chem. 267:1992;14767-14774.
69. Fraser C.M., Chung F.-Z., Wang C.-D., Venter J.C. Site-directed mutagenesis of human β-adrenergic receptors. substitution of aspartic acid-130 by asparagine produces a receptor with high-affinity agonist binding that is uncoupled from adenylate cyclase Proc. Natl. Acad. Sci. USA. 85:1988;5478-5482.
70. Fu D., Ballesteros J.A., Weinstein H., Chen J., Javitch J.A. Residues in the seventh membrane-spanning segment of the dopamine D2 receptor accessible in the binding-site crevice. Biochemistry. 35:1996;11278-11285.
71. Garcia P.D., Onrust R., Bell S.M., Sakmar T.P., Bourne H.R. Transducin-α C-terminal mutations prevent activation by rhodopsin. a new assay using recombinant proteins expressed in cultured cells EMBO J. 14:1995;4460-4469.
72. o-protein complexes using specific GTP-binding-protein antisera. Biochem. J. 306:1995;71-75.
73. Gether U., Lin S., Ghanouni P., Ballesteros J.A., Weinstein H., Kobilka B.K. Agonists induce conformational changes in transmembrane domains III and VI of the β2 adrenergic receptor. EMBO J. 16:1997;6737-6747.
74. Gierschick P., Bouillon T., Jakobs K.H. Receptor-stimulated hydrolysis of guanosine 5′-triphosphate in membrane preparations. Methods Enzymol. 237:1994;13-26.
75. Gilchrist R.L., Ryu K.-S., Ji I., Ji T.H. The luteinizing hormone/chorionic gonadotropin receptor has distinct transmembrane conductors for cAMP and inositol phosphate signals. J. Biol. Chem. 271:1996;19283-19287.
76. Gomeza J., Joly C., Kuhn R., Knöpfel T., Bockaert J., Pin J.-P. The second intracellular loop of the metabotropic glutamate receptor 1 cooperates with the other intracellular domains to control coupling to G-proteins. J. Biol. Chem. 271:1996;2199-2205. a.
77. αq/i proteins. characterization of new antagonists Mol. Pharmacol. 50:1996;923-930. b.
78. i2 Biochemistry. 35:1996;15162-15173.
79. Gu Y.-Z., Schonbrunn A. Coupling specificity between somatostatin receptor sst2A and G proteins. isolation of the receptor-G protein complex with a receptor antibody Mol. Endocrinol. 11:1997;527-537.
80. Gudermann T., Kalkbrenner F., Schultz G. Diversity and selectivity of receptor-G protein interaction. Annu. Rev. Pharmacol. Toxicol. 36:1996;429-459.
81. Gudermann T., Schöneberg T., Schultz G. Functional and structural complexity of signal transduction via G-protein-coupled receptors. Annu. Rev. Neurosci. 20:1997;395-423.
82. Hamm H.E., Deretik D., Arendt A., Hargrave P.A., Koenig B., Hofmann K.P. Site of G protein binding to rhodopsin mapped with synthetic peptides from the α subunit. Science. 241:1988;832-835.
83. Hardman J.G., Gilman A.G., Limbird L.E. Goodman and Gilman's. The Pharmacological Basis of Therapeutics 9:1996;McGraw-Hill, New York.
84. 2c receptor antagonists. J. Biol. Chem. 271:1996;22591-22597.
85. Hasegawa H., Negishi M., Ichikawa A. Two isoforms of the prostaglandin E receptor EP3 subtype different in agonist-independent constitutive activity. J. Biol. Chem. 271:1996;1857-1860.
86. Hedin K.E., Duerson K., Clapham D.E. Specificity of receptor-G protein interactions. searching for the structure behind the signal Cell. Signal. 5:1993;505-518.
87. Heithier H., Fröhlich M., Dees C., Baumann M., Häring M., Gierschick P., Schiltz E., Vaz W.L.C., Hekman M., Helmreich E.J.M. Subunit interactions of GTP-binding proteins. Eur. J. Biochem. 204:1992;1169-1181.
88. q. Proc. Natl. Acad. Sci. USA. 94:1997;751-756.
89. Hermans E., Octave J.-N., Maloteaux J.-M. Interaction of the COOH-terminal domain of the neurotensin receptor with a G protein does not control the phospholipase C activation but is involved in the agonist-induced internalization. Mol. Pharmacol. 49:1996;365-372.
90. Herrada G., Dulac C. A novel family of putative pheromone receptors in mammals with a topographically organized and sexually dimorphic distribution. Cell. 90:1997;763-773.
91. o J. Biol. Chem. 266:1991;12655-12661.
92. Hill-Eubanks D., Burstein E.S., Spalding T.A., Bräuner-Osborne H., Brann M.R. Structure of a G protein-coupling domain of a muscarinic receptor predicted by random saturation mutagenesis. J. Biol. Chem. 271:1996;3058-3065.
93. Hipkin R.W., Liu X., Ascoli M. Truncation of the C-terminal tail of the follitropin receptor does not impair the agonist- or phorbol ester-induced receptor phosphorylation and uncoupling. J. Biol. Chem. 270:1995;26683-26689.
94. Högger P., Shockley M.S., Lameh J., Sadee W. Activating and inactivating mutations in N- and C-terminal i3 loop junctions of muscarinic acetylcholine Hm1 receptors. J. Biol. Chem. 270:1995;7405-7410.
95. s in the transfected Chinese hamster ovary cells. Mol. Pharmacol. 48:1995;392-400.
96. Horstmeyer A., Cramer H., Sauer T., Müller-Esterl W., Schroeder C. Palmitoylation of the endothelin receptor A. differential modulation of signal transduction activity by post-translational modification J. Biol. Chem. 271:1996;20811-20819.
97. Huang Z., Chen Y., Pratt S., Chen T.-H., Bambino T., Shoback D.M., Nissenson R.A. Mutational analysis of the cytoplasmic tail of the G protein-coupled receptor for parathyroid hormone (PTH) and PTH-related protein. effects on receptor expression and signaling Mol. Endocrinol. 9:1995;1240-1249.
98. 2+ signal transduction pathways. J. Biol. Chem. 271:1996;33382-33389.
99. 2 and inhibition of adenylyl cyclase J. Biol. Chem. 269:1994;29565-29570.
100. 1-adrenergic receptor subtypes identify critical residues that modulate active state isomerization. J. Biol. Chem. 271:1996;7956-7964.
101. Iida-Klein A., Guo J., Xie L.Y., Jüppner H., Potts J.T. Jr., Kronenberg H.M., Bringhurst F.R., Abou-Samra A.B., Segre G.V. Truncation of the carboxyl-terminal region of the rat parathyroid hormone (PTH)/PTH-related peptide receptor enhances PTH stimulation of adenylyl cyclase but not phospholipase C. J. Biol. Chem. 270:1995;8458-8465.
102. sα in patients with gain and loss of endocrine function. Nature. 371:1994;164-168.
103. Innamorati G., Sadeghi H., Eberle A.N., Birnbaumer M. Phosphorylation of the V2 vasopressin receptor. J. Biol. Chem. 272:1997;2486-2492.
104. Javitch J.A., Fu D., Chen J. Residues in the fifth membrane-spanning segment of the dopamine D2 receptor exposed in the binding-site crevice. Biochemistry. 34:1995;16433-16439. a.
105. Javitch J.A., Fu D., Chen J., Karlin A. Mapping the binding-site crevice of the dopamine D2 receptor by the substituted-cysteine accessibility method. Neuron. 14:1995;825-831. b.
106. 2 adrenergic receptor alters the orientation of its sixth membrane-spanning segment. J. Biol. Chem. 272:1997;18546-18549.
107. 1 receptor. Eur. J. Pharmacol. (Mol. Pharmacol. Sect.). 288:1995;251-257.
108. Jones S.V.P., Heilman C.J., Brann M.R. Functional responses of cloned muscarinic receptors expressed in CHO-K1 cells. Mol. Pharmacol. 40:1991;242-247.
109. Jung H., Windhaber R., Palm D., Schnackerz K.D. NMR and circular dichroism studies of synthetic peptides derived from the third intracellular loop of the β-adrenoceptor. FEBS Lett. 358:1995;133-136.
110. 1H NMR spectroscopy. Biochemistry. 35:1996;6399-6405.
111. Kalkbrenner F., Dippel E., Wittig B., Schultz G. Specificity of interaction between receptor and G protein. use of antisense techniques to relate G-protein subunits to function Biochim. Biophys. Acta. 1314:1996;125-139.
112. Kallal L., Kurjan J. Analysis of the receptor binding domain of Gpa1p, the Gα subunit involved in the yeast pheromone response pathway. Mol. Cell. Biol. 17:1997;2897-2907.
113. B receptors uncovers similarity to metabotropic glutamate receptors. Nature. 386:1997;239-246.
114. Kelleher D.J., Johnson G.L. Transducin inhibition of light-dependent rhodopsin phosphorylation. evidence for βγ subunit interaction with rhodopsin Mol. Pharmacol. 34:1988;452-460.
115. o J. Biol. Chem. 270:1995;14672-14678.
116. Kisselev O., Gautam N. Specific interaction with rhodopsin is dependent on the γ subunit type in a G protein. J. Biol. Chem. 268:1993;24519-24522.
117. Kisselev O., Ermolaeva M.V., Gautam N. A farnesylated domain in the G protein γ subunit is a specific determinant of receptor coupling. J. Biol. Chem. 269:1994;21399-21403.
118. Kisselev O., Ermolaeva M.V., Gautam N. Efficient interaction with a receptor requires a specific type of prenyl group on the G protein γ subunit. J. Biol. Chem. 270:1995;25356-25358.
119. Kobilka B. Adrenergic receptors as models for G protein-coupled receptors. Annu. Rev. Neurosci. 15:1992;97-114.
120. 2-adrenergic receptors. delineation of domains involved in effector coupling and ligand binding specificity Science. 240:1988;1310-1316.
121. Komatsuzaki K., Murayama Y., Giambarella U., Ogata E., Seino S., Nishimoto I. A novel system that reports the G-protein linked to a given receptor. a study of type 3 somatostatin receptor FEBS Lett. 406:1997;165-170.
122. König B., Arendt A., McDowell J.H., Kahlert M., Hargrave P.A., Hofmann K.P. Three cytoplasmic loops of rhodopsin interact with transducin. Proc. Natl. Acad. Sci. USA. 86:1989;6878-6882.
123. q subunits. Biochemistry. 36:1997;1487-1495. a.
124. q is critical for constraining the selectivity of receptor coupling. J. Biol. Chem. 272:1997;19107-19110. b.
125. q coupling selectivity. J. Biol. Chem. 272:1997;23675-23681. c.
126. Kosugi S., Okajima F., Ban T., Hidaka A., Shenker A., Kohn L.D. Mutation of alanine 623 in the third cytoplasmic loop of the rat thyrotropin (TSH) receptor results in a loss in the phosphoinositide but not cAMP signal induced by TSH and receptor autoantibodies. J. Biol. Chem. 267:1992;24153-24156.
127. Kosugi S., Okajima F., Ban T., Hidaka A., Shenker A., Kohn L.D. Substitutions of different regions of the third cytoplasmic loop of the thyrotropin (TSH) receptor have selective effects on constitutive, TSH-, and TSH receptor autoantibody-stimulated phosphoinositide and 3′,5′-cyclic adenosine monophosphate signal generation. Mol. Endocrinol. 7:1993;1009-1020.
128. 578 in maintaining the inactive conformation of the human lutropin/choriogonadotropin receptor. J. Biol. Chem. 271:1996;31813-31817.
129. Kudo M., Osuga Y., Kobilka B.K., Hsueh A.J.W. Transmembrane regions V and VI of the human luteinizing hormone receptor are required for constitutive activation by a mutation in the third intracellular loop. J. Biol. Chem. 271:1996;22470-22478.
130. Kunkel M.T., Peralta E.G. Charged amino acids required for signal transduction by the m3 muscarinic acetylcholine receptor. EMBO J. 12:1993;3809-3815.
131. 1-adrenoceptor in sealed unilamellar lipid vesicles. Eur. J. Biochem. 197:1991;167-176.
132. Laburthe M., Couvineau A., Gaudin P., Maoret J.-J., Rouyer-Fessard C., Nicole P. Receptors for VIP, PACAP, secretin, GRF, glucagon, GLP-1, and other members of their new family of G protein-linked receptors. structure-function relationship with special reference to the human VIP-1 receptor Ann. NY Acad. Sci. 805:1996;94-111.
133. Lambright D.G., Sondek J., Bohm A., Skiba N.P., Hamm H.E., Sigler P.B. The 2.0 Å crystal structure of a heterotrimeric G protein. Nature. 379:1996;311-319.
134. 1B-adrenergic receptor. J. Biol. Chem. 269:1994;22887-22893.
135. Laugwitz K.-L., Spicher K., Schultz G., Offermanns S. Identification of receptor-activated G proteins. selective immunoprecipitation of photolabeled G-protein α subunits Methods Enzymol. 237:1994;283-294.
136. Laugwitz K.-L., Allgeier A., Offermanns S., Spicher K., Van Sande J., Dumont J.E., Schultz G. The human thyrotropin receptor. a heptahelical receptor capable of stimulating members of all four G protein families Proc. Natl. Acad. Sci. USA. 93:1996;116-120.
137. Law S.F., Reisine T. Changes in the association of G protein subunits with the cloned mouse delta opioid receptor on agonist stimulation. J. Pharmacol. Exp. Ther. 281:1997;1476-1486.
138. Law S.F., Manning D., Reisine T. Identification of the subunits of GTP-binding proteins coupled to somatostatin receptors. J. Biol. Chem. 266:1991;17885-17897.
139. Lechleiter J., Hellmiss R., Duerson K., Ennulat D., David N., Clapham D., Peralta E. Distinct sequence elements control the specificity of G protein activation by muscarinic acetylcholine receptor subtypes. EMBO J. 9:1990;4381-4390.
140. 16 contribute to the specificity of activation by the C5a receptor. Mol. Pharmacol. 47:1995;218-223.
141. Lee N.H., Geoghagen N.S.M., Cheng E., Cline R.T., Fraser C.M. Alanine scanning mutagenesis of conserved arginine/lysine-arginine/lysine-X-X-arginine/lysine G protein-activating motifs on m1 muscarinic acetylcholine receptors. Mol. Pharmacol. 50:1996;140-148.
142. Lefkowitz R.J., Cotecchia S., Samama P., Costa T. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. Trends Pharmacol. Sci. 14:1993;303-307.
143. Lichtarge O., Bourne H.R., Cohen F.E. Evolutionary conserved Gαβγ binding surfaces support a model of the G protein-receptor complex. Proc. Natl. Acad. Sci. USA. 93:1996;7507-7511.
144. s. requirement for multiple cytoplasmic domains in the coupling process J. Biol. Chem. 266:1991;4816-4821.
145. Liu J., Wess J. Different single receptor domains determine the distinct G protein coupling profiles of members of the vasopressin receptor family. J. Biol. Chem. 271:1996;8772-8778.
146. Liu J., Conklin B.R., Blin N., Yun J., Wess J. Identification of a receptor/G-protein contact site critical for signalling specificity and G-protein activation. Proc. Natl. Acad. Sci. USA. 92:1995;11642-11646.
147. Liu J., Blin N., Conklin B.R., Wess J. Molecular mechanisms involved in muscarinic acetylcholine receptor-mediated G protein activation studied by insertion mutagenesis. J. Biol. Chem. 270:1996;6172-6178.
148. Lu Z.-L., Curtis C.A., Jones P.G., Pavia J., Hulme E.C. The role of the aspartate-arginine-tyrosine triad in the m1 muscarinic receptor. mutations of aspartate 122 and tyrosine 124 decrease receptor expression but do not abolish signaling Mol. Pharmacol. 51:1997;234-241.
149. 2+ in rat portal vein myocytes. J. Biol. Chem. 272:1997;10095-10102. a.
150. 2+ entry in rat portal vein myocytes. J. Biol. Chem. 272:1997;5261-5268. b.
151. Martin E.L., Rens-Domiano S., Schatz P.J., Hamm H. Potent peptide analogues of a G protein receptor-binding region obtained with a combinatorial library. J. Biol. Chem. 271:1996;361-366.
152. Matesic D.F., Manning D.R., Luthin G.R. Tissue-dependent association of muscarinic acetylcholine receptors with guanine nucleotide-binding regulatory proteins. Mol. Pharmacol. 40:1991;347-353.
153. Mathi S., Chan Y., Li X., Wheeler M.B. Scanning of the glucagon-like peptide-1 receptor localizes G protein-activating determinants primarily to the N terminus of the third intracellular loop. Mol. Endocrinol. 11:1997;424-432.
154. Matsunami H., Buck L.B. A multigene family encoding a diverse array of putative pheromone receptors in mammals. Cell. 90:1997;775-784.
155. Matus-Leibovitch N., Nussenzweig D.R., Gershengorn M.C., Oron Y. Truncation of the thyrotropin-releasing hormone receptor carboxyl tail cause constitutive activity and leads to impaired responsiveness in Xenopus oocytes and AtT20 cells. J. Biol. Chem. 270:1995;1041-1047.
156. Mazzoni M.R., Hamm H.E. Interaction of transducin with light-activated rhodopsin protects it from proteolytic digestion by trypsin. J. Biol. Chem. 271:1996;30034-30040.
157. Merkouris M., Dragatsis I., Megaritis G., Konidakis G., Zioudrou C., Milligan G., Georgoussi Z. Identification of the critical domains of the δ-opioid receptor involved in G protein coupling using site-specific synthetic peptides. Mol. Pharmacol. 50:1996;985-993.
158. Migeon J.C., Nathanson N.M. Differential regulation of cAMP-mediated gene transcription by m1 and m4 muscarinic acetylcholine receptors. J. Biol. Chem. 269:1994;9767-9773.
159. oα subunits. J. Biol. Chem. 272:1995;16070-16074.
160. Milligan G. Signal sorting by G-protein-linked receptors. Adv. Pharmacol. 32:1995;1-29.
161. Milligan G., Shah B.H., Mullaney I., Grassie M.A. Biochemical approaches to examine the specificity of interactions between receptors and guanine nucleotide binding proteins. J. Recept. Signal Transduct. Res. 15:1995;253-265.
162. 2+ release in mouse duodenal myocytes. Br. J. Pharmacol. 121:1997;451-458.
163. Moro O., Lameh J., Högger P., Sadée W. Hydrophobic amino acid in the i2 loop plays a key role in receptor-G protein coupling. J. Biol. Chem. 268:1993;22273-22276.
164. Moro O., Shockley M.S., Lameh J., Sadée W. Overlapping multi-site domains of the muscarinic cholinergic Hm1 receptor involved in signal transduction and sequestration. J. Biol. Chem. 269:1994;6651-6655.
165. Mumby S.M., Kleuss C., Gilman A.G. Receptor regulation of G-protein palmitoylation. Proc. Natl. Acad. Sci. USA. 91:1994;2800-2804.
166. Münch G., Dees C., Hekman M., Palm D. Multisite contacts involved in coupling of the β-adrenergic receptor with the stimulatory guanine-nucleotide-binding regulatory protein. Eur. J. Biochem. 198:1991;357-364.
167. Namba T., Sugimoto Y., Negishi M., Irie A., Ushikubi F., Kakizuka A., Ito S., Ichikawa A., Narumiya S. Alternative splicing of C-terminal tail of prostaglandin E receptor subtype EP3 determines G-protein specificity. Nature. 365:1993;166-170.
168. 2-adrenergic recepors determines subtype-specific coupling to cAMP production. J. Biol. Chem. 272:1997;9703-9708.
169. Neer E.J. Heterotrimeric G proteins. organizers of transmembrane signals Cell. 80:1995;249-257.
170. Neubig R.R. Membrane organization in G-protein mechanisms. FASEB J. 8:1994;939-946.
171. Nussenzweig D.R., Thaw C.N., Gershengorn M.C. Inhibition of inositol phosphate second messenger formation by intracellular loop one of a human calcitonin receptor. expression and mutational analysis of synthetic receptor genes J. Biol. Chem. 269:1994;28123-28129.
172. 7 receptor. importance of the third intracellular loop for receptor-G-protein interaction FEBS Lett. 412:1997;321-324.
173. 2-adrenergic receptor. J. Biol. Chem. 263:1988;15985-15992.
174. 16 couple a wide variety of receptors to phospholipase C. J. Biol. Chem. 270:1995;15175-15180.
175. 2 and thrombin receptors in human platelets. Proc. Natl. Acad. Sci. USA. 91:1994;504-508. a.
176. q/11. Mol. Pharmacol. 45:1994;890-898. b.
177. i1 leading to the inhibition of adenylate cyclase in transfected cell lines. J. Pharmacol. Exp. Ther. 278:1996;354-360.
178. 2-adrenergic receptors based upon characteristics in primary structure. J. Biol. Chem. 267:1992;8342-8346.
179. s activator region of the β2-adrenergic receptor that is autoregulated via protein kinase A-dependent phosphorylation. Cell. 67:1991;723-730.
180. B. its critical role in G protein coupling and differential requirement for the cytoplasmic tail by G protein subtypes J. Biol. Chem. 272:1997;21589-21596.
181. 2a-adrenergic receptor-GTP-binding protein complexes using GTP-binding protein selective antisera. J. Biol. Chem. 267:1992;14826-14831.
182. 2a adenosine receptors J. Biol. Chem. 272:1997;337-344.
183. Oliveira L., Paiva A.C.M., Sander C., Vriend G. A common step for signal transduction in G protein-coupled receptors. Trends Pharmacol. Sci. 15:1994;170-172.
184. Onrust R., Herzmark P., Chi P., Garcia P.D., Lichtarge O., Kingsley C., Bourne H.R. Receptor and βγ binding sites in the α subunit of the retinal G protein transducin. Science. 275:1997;381-384.
185. tα on rhodopsin and guanine nucleotide binding. J. Biol. Chem. 270:1995;31052-31058.
186. Parker E.M., Ross E.M. Truncation of the extended carboxyl-terminal domain increases the expression and regulatory activity of the avian β-adrenergic receptor. J. Biol. Chem. 266:1991;9987-9996.
187. Pebay-Peyroula E., Rummel G., Rosenbusch J.P., Landau E.M. X-ray structure of bacteriorhodopsin at 2.5 Angstroms from microcrystals grown in lipidic cubic phases. Science. 277:1997;1676-1681.
188. Perez D.M., Hwa J., Gaivin R., Mathur M., Brown F., Graham R.M. Constitutive activation of a single effector pathway. evidence for multiple activation states of a G protein-coupled receptor Mol. Pharmacol. 49:1996;112-122.
189. Phillips W.J., Cerione R.A. Rhodopsin/transducin interactions. I. Characterization of the binding of transducin-βγ subunit complex to rhodopsin using fluorescence spectroscopy J. Biol. Chem. 267:1992;17032-17039.
190. Phillips W.J., Wong S.C., Cerione R.A. Rhodopsin/transducin interactions. II. Influence of the transducin-βγ subunit complex on the coupling of the transducin-α subunit to rhodopsin J. Biol. Chem. 267:1992;17040-17046.
191. Pin J.-P., Joly C., Heinemann S.F., Bockaert J. Domains involved in the specificity of G protein activation in phospholipase C-coupled metabotropic glutamate receptors. EMBO J. 13:1994;342-348.
192. Pisegna J.R., Wank S.A. Cloning and characterization of the signal transduction of four splice variants of the human pituitary adenylate cyclase activating polypeptide receptor. J. Biol. Chem. 271:1996;17267-17274.
193. 1b-adrenergic receptor is initiated by disruption of an interhelical salt bridge constraint. J. Biol. Chem. 271:1996;28318-28323.
194. Prossnitz E.R., Schreiber R.E., Bokoch G.M., Ye R.D. Binding of low affinity N-formyl peptide receptors to G protein. characterization of a novel inactive receptor intermediate J. Biol. Chem. 270:1995;10686-10694.
195. iα Mol. Endocrinol. 11:1997;538-549.
196. Rao V.R., Oprian D.D. Activating mutations of rhodopsin and other G protein-coupled receptors. Annu. Rev. Biophys. Biomol. Struct. 25:1996;287-314.
197. Rao V.R., Cohen G.B., Oprian D.D. Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature. 367:1994;639-642.
198. s and evoke high affinity agonist binding to β-adrenergic receptors J. Biol. Chem. 269:1994;21519-21525.
199. 11 subunits. J. Biol. Chem. 270:1995;21765-21771.
200. Raymond J.R. Multiple mechanisms of receptor-G protein signaling specificity. Am. J. Physiol. 269:1995;F141-F158.
201. Rens-Domiano S., Hamm H.E. Structural and functional relationships of heterotrimeric G-proteins. FASEB J. 9:1995;1059-1066.
202. Rhee S.G., Bae Y.S. Regulation of phosphoinositide-specific phospholipase C isozymes. J. Biol. Chem. 272:1997;15045-15048.
203. Robbins L.S., Nadeau J.H., Johnson K.R., Kelly M.A., Roselli-Rehfuss L., Baack E., Mountjoy K.G., Cone R.D. Pigmentation phenotypes of variant extension locus alleles result from point mutations that alter MSH receptor function. Cell. 72:1993;827-834.
204. Robinson P.R., Cohen G.B., Zhukovsky E.A., Oprian D.D. Constitutively active mutants of rhodopsin. Neuron. 9:1992;719-725.
205. Rosenthal W., Antaramian A., Gilbert S., Birnbaumer M. Nephrogenic diabetes insipidus. a V2 vasopressin receptor unable to stimulate adenylyl cyclase J. Biol. Chem. 268:1993;13030-13033.
206. Ross E.M. Palmitoylation in G-protein signaling pathways. Curr. Biol. 5:1995;107-109.
207. Ruggieri M.R., Colton M.D., Wang P., Wang J., Smyth R.J., Pontari M.A., Luthin G.R. Human prostate muscarinic receptor subtypes. J. Pharmacol. Exp. Ther. 274:1995;976-982.
208. Sano T., Ohyama K., Yamano Y., Nakagomi Y., Nakazawa S., Kikyo M., Shirai H., Blank J.H., Inagami T. A domain for G protein coupling in carboxyl-terminal tail of rat angiotensin II receptor type 1A. J. Biol. Chem. 272:1997;23631-23636.
209. Savarese T.M., Fraser C.M. In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. Biochem. J. 283:1992;1-19.
210. 1B-adrenergic receptor. role of highly conserved polar amino acids in receptor activation EMBO J. 15:1996;3566-3578.
211. 1B-adrenergic receptor. potential role of protonation and hydrophobicity of a highly conserved aspartate Proc. Natl. Acad. Sci. USA. 94:1997;808-813.
212. Schertler G.F.X., Villa C., Henderson R. Projection structure of rhodopsin. Nature. 362:1993;770-772.
213. 2. Eur. J. Biochem. 228:1995;23-30.
214. Schneider H., Feyen J.H.M., Seuwen K. A C-terminally truncated human parathyroid hormone receptor is functional and activates multiple G proteins. FEBS Lett. 351:1994;281-285.
215. Schreiber R.E., Prossnitz E.R., Ye R.D., Cochrane C.G., Bokoch G.M. Domains of the human neutrophil N-formyl peptide receptor involved in G protein coupling. mapping with receptor-derived peptides J. Biol. Chem. 269:1994;326-331.
216. Schwartz T.W. Locating ligand-binding sites in 7TM receptors by protein engineering. Curr. Opin. Biotechnol. 5:1994;434-444.
217. Segaloff D.L., Ascoli M. The lutropin/choriogonadotropin receptor ... 4 years later. Endocr. Rev. 14:1993;324-347.
218. iα proteins J. Biol. Chem. 269:1994;23120-23127.
219. qα (pertussis toxin-insensitive) G proteins in αT3-1 gonadotroph cells reflects increased G protein turnover but not alterations in mRNA levels. Proc. Natl. Acad. Sci. USA. 92:1995;1886-1890.
220. Sheikh S.P., Zvyaga T.A., Lichtarge O., Sakmar T.P., Bourne H.R. Rhodopsin activation blocked by metal-ion-binding sites linking transmembrane helices C and F. Nature. 383:1996;347-350.
221. Shenker A. G protein-coupled receptor structure and function. the impact of disease-causing mutations Baillieres Clin. Endocrin. Metab. 9:1995;427-451.
222. Shenker A. Disorders caused by mutations of the lutropin/choriogonadotropin receptor gene. Spiegel A.M. Contemporary Endocrinology. G Proteins, Receptors, and Disease:1998;139-152 Humana Press, Totowa.
223. Shirai H., Takahashi K., Katada T., Inagami T. Mapping of G protein coupling sites of the angiotensin II type 1 receptor. Hypertension. 25(Part 2):1995;726-730.
224. 2 agonists J. Biol. Chem. 271:1996;7574-7582.
225. Sondek J., Bohm A., Lambright D.G., Hamm H.E., Sigler P.B. Crystal structure of a G protein βγ dimer at 2.1 Å resolution. Nature. 379:1996;369-374.
226. Ach, in intact cells. Proc. Natl. Acad. USA. 94:1997;7921-7926.
227. Spengler D., Waeber C., Pantaloni C., Holsboer F., Bockaert J., Seeburg P.H., Journot L. Differential signal transduction by five splice variants of the PACAP receptor. Nature. 365:1993;170-175.
228. Spiegel A.M. G protein-regulated effectors. Spiegel A.M., Jones T.L.Z., Simonds W.F., Weinstein L.S. G Proteins, Molecular Biology Intelligence Unit. 1994;18-24 R. G. Landes Company, Austin.
229. Spiegel A.M. Defects in G protein-coupled signal transduction in human disease. Annu. Rev. Physiol. 58:1996;143-170.
230. Spiegel A.M., Shenker A., Weinstein L.S. Receptor-effector coupling by G proteins. implications for normal and abnormal signal transduction Endocr. Rev. 13:1992;536-565.
231. q/11α by the gonadotropin-releasing hormone receptor. Mol. Endocrinol. 11:1997;738-746.
232. Strader C.D., Fong T.M., Tota M.R., Underwood D., Dixon R.A.F. Structure and function of G protein-coupled receptors. Annu. Rev. Biochem. 63:1994;101-132.
233. Sunahara R.K., Dessauer C.W., Gilman A.G. Complexity and diversity of mammalian adenylyl cyclases. Annu. Rev. Pharmacol. Toxicol. 36:1996;461-480.
234. 2-adrenoceptor that blocks coupling to potassium but not calcium currents. Science. 257:1992;977-980.
235. A/B chimeras J. Biol. Chem. 270:1995;10072-10078.
236. Takigawa M., Sakurai T., Kasuya Y., Abe Y., Masaki T., Goto K. Molecular identification of guanine-nucleotide-binding regulatory proteins which couple to endothelin receptors. Eur. J. Biochem. 228:1995;102-108.
237. 2 adrenergic receptor third intracellular loop peptide to Gβ and the amino terminus of Gα J. Biol. Chem. 269:1994;27618-27624.
238. Taylor J.M., Jacob-Mosier G.G., Lawton R.G., VanDort M., Neubig R.R. Receptor and membrane interaction sites on Gβ a receptor-derived peptide binds to the carboxyl terminus J. Biol. Chem. 271:1996;3336-3339.
239. i-coupled receptors. Mol. Pharmacol. 52:1997;38-45.
240. Unger V.M., Hargrave P.A., Baldwin J.M., Schertler G.F.X. Arrangement of rhodopsin transmembrane α-helices. Nature. 389:1997;203-206.
241. Unson C.G., Cypess A.M., Kim H.N., Goldsmith P.K., Carruthers C.J.L., Merrifield R.B., Sakmar T.P. Characterization of deletion and truncation mutants of the rat glucagon receptor. seven transmembrane segments are necessary for receptor transport to the plasma membrane and glucagon binding J. Biol. Chem. 270:1995;27720-27727.
242. 2+ channels in mouse heart. Proc. Natl. Acad. Sci. USA. 94:1997;1727-1732.
243. Van Leeuwen D.H., Eisenstein J., O'Malley K., MacKenzie R.G. Characterization of a chimeric human dopamine D3/D2 receptor functionally coupled to adenylyl cyclase in Chinese hamster ovary cells. Mol. Pharmacol. 48:1995;344-351.
244. Van Rhee A.M., Jacobson K.A. Molecular architecture of G protein-coupled receptors. Drug Dev. Res. 37:1996;1-38.
245. q-like G proteins in chimeric receptors. additional evidence for a common transmembrane signalling and G protein coupling mechanism in G protein-coupled receptors J. Biol. Chem. 272:1997;6898-6902.
246. Voyno-Yasenetskaya T., Conklin B.R., Gilbert R.L., Hooley R., Bourne H.R., Barber D.L. Gα13 stimulates Na-H exchange. J. Biol. Chem. 269:1994;4721-4724.
247. Wade S.M., Dalman H.M., Yang S.-Z., Neubig R.R. Multisite interactions of receptors and G proteins. enhanced potency of dimeric receptor peptides in modifying G protein function Mol. Pharmacol. 45:1994;1191-1197.
248. 2. Cell. 83:1995;1047-1058.
249. q coupling by the use or receptor chimeras. J. Biol. Chem. 270:1995;16677-16682.
250. Wang H.-L. Basic amino acids at the C-terminus of the third intracellular loop are required for the activation of phospholipase C by cholecystokinin-B receptors. J. Neurochem. 68:1997;1728-1735.
251. 7 subunit suggests a role in hormone regulation of adenylylcyclase activity. J. Biol. Chem. 272:1997;26040-26048.
252. Wang Z., Wang H., Ascoli M. Mutation of a highly conserved acidic residue present in the second intracellular loop of G-protein-coupled receptors does not impair hormone binding or signal transduction of the luteinizing hormone/chorionic gonadotropin receptor. Mol. Endocrinol. 7:1993;85-93.
253. Watson S., Arkinstall S. The G-Protein Linked Receptor - Facts Book. 1994;Academic Press, London.
254. sα Cell. 77:1994;1063-1070.
255. Wedegaertner P.B., Wilson P.T., Bourne H.R. Lipid modifications of trimeric G proteins. J. Biol. Chem. 270:1995;503-506.
256. Wenkert D., Schöneberg T., Merendino J.J., Pena M.S.R., Vinitsky R., Goldsmith P.K., Wess J., Spiegel A.M. Functional characterization of five V2 vasopressin receptor gene mutations. Mol. Cell. Endocrinol. 124:1996;43-50.
257. Wess J. Molecular biology of muscarinic acetylcholine receptors. Crit. Rev. Neurobiol. 10:1996;69-99.
258. Wess J. G protein-coupled receptors. molecular mechanisms involved in receptor activation and selectivity of G protein recognition FASEB J. 11:1997;346-354.
259. Wess J., Brann M.R., Bonner T.I. Identification of a small intracellular region of the muscarinic m3 receptor as a determinant of selective coupling to PI turnover. FEBS Lett. 258:1989;133-136.
260. Wess J., Bonner T.I., Brann M.R. Chimeric m2/m3 muscarinic receptors. role of carboxyl terminal receptor domains in selectivity of ligand binding and coupling to phosphoinositide hydrolysis Mol. Pharmacol. 38:1990;872-877. a.
261. Wess J., Bonner T.I., Dörje F., Brann M.R. Delineation of muscarinic receptor selectivity of coupling to guanine-nucleotide binding proteins and second messengers. Mol. Pharmacol. 38:1990;517-523. b.
262. Wess J., Nanavati S., Vogel Z., Maggio R. Functional role of proline and tryptophan residues highly conserved among G protein-coupled receptors studied by mutational analysis of the m3 muscarinic receptor. EMBO J. 12:1993;331-338.
263. West R.E., Moss J., Vaughan M., Liu T., Liu T.Y. Pertussis toxin-catalyzed ADP-ribosylation of transducin. cysteine 347 is the ADP-ribose acceptor site J. Biol. Chem. 260:1985;14428-14430.
264. Wieland T., Jakobs K.H. Measurement of receptor-stimulated guanosine 5′-O-(γ-thio)triphosphate binding by G proteins. Methods Enzymol. 237:1994;3-13.
265. 1C adrenergic receptors. J. Biol. Chem. 270:1995;17196-17203.
266. Wong S.K.-F., Ross E.M. Chimeric muscarinic cholinergic. β-adrenergic receptors that are functionally promiscuous among G proteins J. Biol. Chem. 269:1994;18968-18976.
267. s in response to muscarinic agonists J. Biol. Chem. 265:1990;6219-6224.
268. Wozniak M., Keefer J.R., Saunders C., Limbird L.E. Differential targeting and retention of G protein-coupled receptors in polarized epithelial cells. J. Recept. Signal. Transduct. Res. 17:1997;373-383.
269. Wu D., LaRosa G.J., Simon M.I. G protein-coupled signal transduction pathways for interleukin-8. Science. 261:1993;101-103.
270. Wu V., Yang M., McRoberts J.A., Ren J., Seensalu R., Zeng N., Dagrag M., Birnbaumer M., Walsh J.H. First intracellular loop of the human cholecystokinin-A receptor is essential for cyclic AMP signalling in transfected HEK-293 cells. J. Biol. Chem. 272:1997;9037-9042.
271. Xiong Y., Xie L.Y., Abou-Samra A.-B. Signaling properties of mouse and human corticotropin-releasing factor (CRF) receptors. decreased coupling efficiency of human type II CRF receptor Endocrinology. 136:1995;1828-1834.
272. Yang K., Farrens D.L., Altenbach C., Farahbakhsh Z.T., Hubbell W.L., Khorana H.G. Structure and function in rhodopsin. Cysteines 65 and 316 are in proximity in a rhodopsin mutant as indicated by disulfide formation and interactions between attached spin labels. Biochemistry. 35:1996;14040-14046. a.
273. Yang K., Farrens D.L., Hubbell W.L., Khorana H.G. Structure and function in rhodopsin. Single cysteine substitution mutants in the cytoplasmic interhelical E-F loop region show position-specific effects in transducin activation. Biochemistry. 35:1996;12464-12469. b.
274. Yasuda H., Lindorfer M.A., Woodfork K.A., Fletcher J.E., Garrison J.C. Role of the prenyl group on the G protein γ subunit in coupling trimeric G proteins to A1 adenosine receptors. J. Biol. Chem. 271:1996;18588-18595.
275. Yeagle P.L., Alderfer J.L., Albert A.D. Three-dimensional structure of the cytoplasmic face of the G protein receptor rhodopsin. Biochemistry. 36:1997;9649-9654. a.
276. Yeagle P.L., Alderfer J.L., Salloum A.C., Ali L., Albert A.D. The first and second cytoplasmic loops of the G-protein receptor, rhodopsin, independently form β-turns. Biochemistry. 36:1997;3864-3869. b.
277. Yu H., Kono M., McKee T.D., Oprian D.D. A general method for mapping tertiary contacts between amino acid residues in membrane-embedded proteins. Biochemistry. 34:1995;14963-14969.
278. 3 in the rat fetus. J. Biol. Chem. 271:1996;15026-15033.
279. Zhu S.Z., Wang S.Z., Hu J., El-Fakahany E.E. An arginine residue conserved in most G protein-coupled receptors is essential for the function of the m1 muscarinic receptor. Mol. Pharmacol. 45:1994;517-523.
280. 16 and evidence for a synergistic interaction between Gβγ and the α subunit of a receptor-activated G protein Proc. Natl. Acad. Sci. USA. 93:1996;2827-2831.
281. s-coupled receptors and dependent on receptor density. Mol. Pharmacol. 46:1994;460-469.